Archived articles

William moss

Coronavirus
Key COVID-19 metrics decline, but experts say it's far from over
Published Feb 28, 2022
COVID-19 is inching toward endemic status in the U.S., but a clear seasonal pattern has yet to emerge. Meanwhile less than 66% of the total population has been vaccinated.
Coronavirus
Experts discuss risks of ending mask mandates too soon
Published Feb 11, 2022
Indoor winter gatherings, low vaccination rates among eligible children are reasons for concern, according Hopkins experts
Coronavirus
COVID-19 cases surge but not deaths as pandemic enters third year
Published Jan 7, 2022
In briefing Friday, experts agree that vaccination is the reason behind the lower death rate despite the soaring number of people infected with COVID-19
Q+A
Without global vaccinations, further variants ahead
Published Dec 21, 2021
Vaccine experts Anna Durbin and William Moss explain how vaccination prevents viral mutation, discuss remaining barriers to global vaccine access
COVID-19 briefing
Omicron variant is likely everywhere, delta cases increasing
Published Dec 6, 2021
Delta remains dominant around the world while omicron emerges, though time will tell whether the new variant will challenge vaccine effectiveness
Q+A
COVID vaccines have been OK'd for kids. Now what?
Published Nov 4, 2021
Emergency use authorization for Pfizer/BioNTech's vaccine is unlikely to lead to widespread vaccinations among the nation's 28 million 5- to 11-year-olds, Hopkins vaccine expert William Moss says
Q+A
As Africa goes unvaccinated, U.S. remains awash in shots
Published Nov 2, 2021
Johns Hopkins vaccine expert William Moss discusses inequities in the race to vaccinate the world against COVID-19 and why the U.S. and other wealthy nations should help poorer countries catch up
Coronavirus
COVID-19 this week: Booster shots and U.S. strategies
Published Oct 15, 2021
Johns Hopkins experts Beth Blauer and William Moss discuss booster shots, global vaccine supply strategies, data collection issues
Q+A
Pfizer moves toward booster approval, vaccine for children
Published Sept 22, 2021
FDA, CDC expected to finalize decisions about Pfizer booster doses in same week the company announced that studies of its vaccine for children show promising results
Coronavirus
COVID-19 this week: No time for complacency
Published Sept 3, 2021
Hopkins experts Bill Moss and Jennifer Nuzzo discuss a slowdown in new cases, tempering our vaccine expectations, booster shots, and a vaccine timeline for kids under 12